Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy Alik Farber, MD, Tze-Woei Tan, MD, Denis Rybin, MS, Jeffrey A. Kalish, MD, Naomi M. Hamburg, MD, Gheorghe Doros, PhD, Philip P. Goodney, MD, Jack L. Cronenwett, MD Journal of Vascular Surgery Volume 57, Issue 3, Pages 635-641 (March 2013) DOI: 10.1016/j.jvs.2012.09.017 Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 1 Relative utilization of dextran by surgeons within the Vascular Study Group of Northern New England. Journal of Vascular Surgery 2013 57, 635-641DOI: (10.1016/j.jvs.2012.09.017) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 2 Effect of dextran use on unadjusted patient outcomes (A) and length of stay (LOS) (B). The error bars extend one standard error from the estimate in each direction. CHF, Congestive heart failure; MI, myocardial infarction. Journal of Vascular Surgery 2013 57, 635-641DOI: (10.1016/j.jvs.2012.09.017) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 3 Independent effect of dextran on clinical outcomes and length of stay (LOS) based on multivariable analysis of the entire carotid endarterectomy cohort. †Odds ratio (95% confidence interval [CI]) reported. ‡Means ratio (95% CI) reported. CHF, Congestive heart failure; MI, myocardial infarction. Journal of Vascular Surgery 2013 57, 635-641DOI: (10.1016/j.jvs.2012.09.017) Copyright © 2013 Society for Vascular Surgery Terms and Conditions